arrow
H

Hyuk-Soo Seo

Dana-Farber Cancer Institute
H指数:37
被引数:4,699

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AI-enhanced adaptive virtual screening of large libraries for ligand discovery

用于配体发现的大型文库的AI增强自适应虚拟筛选

2026-09-010
OA
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma

IRF4的药理学靶向作为多发性骨髓瘤的治疗策略

2026-05-280
PRE
A druggable redox switch on SHP1 controls macrophage inflammation

一种可药物调控的SHP1氧化还原开关控制巨噬细胞炎症

2026-03-120
PRE
Discovery of a small molecule TLR3 agonist adjuvant

小分子TLR3激动剂佐剂的发现

2025-12-040
OAAI
Pharmacologic interrogation of USP28 cellular function in p53 signaling

USP28细胞功能在p53信号通路中的药理学研究

2025-09-020
PRE
Targeting transcription factors through an IMiD independent zinc finger domain

通过IMiD非依赖性锌指域靶向转录因子

2025-05-140
OA
Leveraging relaxation-optimized 1H-13CF correlations in 4-19F-phenylalanine as atomic beacons for probing structure and dynamics of large proteins

利用弛豫优化的1H-13C相关信号在4-19F-苯丙氨酸中的原子探针作用,探究大蛋白的结构与动态特性

2025-05-050
PRE
Ergothioneine controls mitochondrial function and exercise performance via direct activation of MPST

谷胱甘肽硫转移酶通过直接激活MPST来调控线粒体功能和运动表现。

2025-02-010
PRE
Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors

开源亲电性片段筛选平台,用于识别UCHL1共价抑制剂的化学起始点

2024-12-010
OAAI
BAD BH3 Helices BCL-2 Mutants That Cause Venetoclax Resistance

BAD BH3螺旋BCL-2突变体导致Venetoclax耐药性

BLOOD
IF23.1
2024-11-050
PRE
BAF COMPLEX PERTURBATION AS A NOVEL THERAPEUTIC OPPORTUNITY IN H3K27M PEDIATRIC GLIOMA

BAF复杂扰动作为H3K27M小儿神经胶质瘤的新治疗机会

2023-06-120
OAAI
Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90a

Irisin通过其整合素受体在涉及细胞外Hsp90a的两步过程中发挥作用

2023-06-0119
OAAI
Lactate regulates cell cycle by remodelling the anaphase promoting complex

乳酸通过重塑后期促进复合物来调节细胞周期

Nature
IF48.5
2023-03-150
PRE
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice (vol 8, 18, 2023)
2023-03-030
OAAI
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease

肠道微生物代谢5-ASA降低其在炎症性肠病中的临床疗效

2023-02-2360
OA
Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor

用共价肌酸激酶抑制剂消耗肌酸磷酸原能量

2023-02-2320
OA